These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28011588)

  • 21. Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice.
    Fontana Estevez FS; Betazza MC; Miksztowicz V; Seropian IM; Silva MG; Penas F; Touceda V; Selser C; Villaverde A; Goren N; Cianciulli TF; Medina V; Morales C; Gironacci M; González GE
    Cell Physiol Biochem; 2022 Aug; 56(4):353-366. PubMed ID: 35959709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-2 mediates a mechanism of metabolic cardioprotection consisting of negative regulation of the sterol regulatory element-binding protein-2/3-hydroxy-3-methylglutaryl-CoA reductase pathway in the heart.
    Wang X; Berry E; Hernandez-Anzaldo S; Takawale A; Kassiri Z; Fernandez-Patron C
    Hypertension; 2015 Apr; 65(4):882-8. PubMed ID: 25646300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction.
    Zamilpa R; Ibarra J; de Castro Brás LE; Ramirez TA; Nguyen N; Halade GV; Zhang J; Dai Q; Dayah T; Chiao YA; Lowell W; Ahuja SS; D'Armiento J; Jin YF; Lindsey ML
    J Mol Cell Cardiol; 2012 Nov; 53(5):599-608. PubMed ID: 22884843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9.
    DeLeon-Pennell KY; de Castro Brás LE; Iyer RP; Bratton DR; Jin YF; Ripplinger CM; Lindsey ML
    J Mol Cell Cardiol; 2014 Nov; 76():218-26. PubMed ID: 25240641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a "Western-style diet" by increasing PPAR α and γ expression and reducing TC, MMP-9, and Cat S levels.
    Qin YW; Ye P; He JQ; Sheng L; Wang LY; Du J
    Acta Pharmacol Sin; 2010 Oct; 31(10):1350-8. PubMed ID: 20835264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
    Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-9-dependent mechanisms of reduced contractility and increased stiffness in the aging heart.
    Padmanabhan Iyer R; Chiao YA; Flynn ER; Hakala K; Cates CA; Weintraub ST; de Castro Brás LE
    Proteomics Clin Appl; 2016 Jan; 10(1):92-107. PubMed ID: 26415707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
    Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
    Zavadzkas JA; Plyler RA; Bouges S; Koval CN; Rivers WT; Beck CU; Chang EI; Stroud RE; Mukherjee R; Spinale FG
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1394-402. PubMed ID: 18689500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice.
    Shen JZ; Morgan J; Tesch GH; Fuller PJ; Young MJ
    Endocrinology; 2014 Mar; 155(3):1057-66. PubMed ID: 24428529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
    Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
    Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
    J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
    Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
    J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
    Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Building a better infarct: Modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction.
    Voorhees AP; DeLeon-Pennell KY; Ma Y; Halade GV; Yabluchanskiy A; Iyer RP; Flynn E; Cates CA; Lindsey ML; Han HC
    J Mol Cell Cardiol; 2015 Aug; 85():229-39. PubMed ID: 26080361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice.
    Moritani T; Iwai M; Kanno H; Nakaoka H; Iwanami J; Higaki T; Ishii E; Horiuchi M
    J Am Soc Hypertens; 2013; 7(4):259-66. PubMed ID: 23608725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathepsin A contributes to left ventricular remodeling by degrading extracellular superoxide dismutase in mice.
    Hohl M; Mayr M; Lang L; Nickel AG; Barallobre-Barreiro J; Yin X; Speer T; Selejan SR; Goettsch C; Erb K; Fecher-Trost C; Reil JC; Linz B; Ruf S; Hübschle T; Maack C; Böhm M; Sadowski T; Linz D
    J Biol Chem; 2020 Sep; 295(36):12605-12617. PubMed ID: 32647007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload.
    Riley HJ; Kelly RR; Van Laer AO; Neff LS; Dasgupta S; Baicu CF; McDonald LT; LaRue AC; Zile MR; Bradshaw AD
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H604-H612. PubMed ID: 33306449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
    Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
    Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.